AACR logo

Advertisement

Table of Contents

Highlights

Highlights

Highlights of This Issue

Mol Cancer Res September 1 2015 13 (9) 1263-1263;

Review

Review

The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas

Ruth Nussinov, Serena Muratcioglu, Chung-Jung Tsai, Hyunbum Jang, Attila Gursoy and Ozlem Keskin

Mol Cancer Res September 1 2015 13 (9) 1265-1273; DOI:10.1158/1541-7786.MCR-15-0165

Cell Death and Survival

Cell Death and Survival

VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells

Xiangcang Ye, Fan Fan, Rajat Bhattacharya, Seth Bellister, Delphine R. Boulbes, Rui Wang, Ling Xia, Cristina Ivan, Xiaofeng Zheng, George A. Calin, Jing Wang, Xiongbin Lu and Lee M. Ellis

Mol Cancer Res September 1 2015 13 (9) 1274-1282; DOI:10.1158/1541-7786.MCR-15-0061
Cell Death and Survival

Ca²⁺-Activated IK K⁺ Channel Blockade Radiosensitizes Glioblastoma Cells

Benjamin Stegen, Lena Butz, Lukas Klumpp, Daniel Zips, Klaus Dittmann, Peter Ruth and Stephan M. Huber

Mol Cancer Res September 1 2015 13 (9) 1283-1295; DOI:10.1158/1541-7786.MCR-15-0075

DNA Damage and Repair

DNA Damage and Repair

Suppression of Reserve MCM Complexes Chemosensitizes to Gemcitabine and 5-Fluorouracil

Victoria L. Bryant, Roy M. Elias, Susan M. McCarthy, Timothy J. Yeatman and Mark G. Alexandrow

Mol Cancer Res September 1 2015 13 (9) 1296-1305; DOI:10.1158/1541-7786.MCR-14-0464

Genomics

Genomics

Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors

Jonathan Hensel, Jason E. Duex, Charles Owens, Garrett M. Dancik, Michael G. Edwards, Henry F. Frierson and Dan Theodorescu

Mol Cancer Res September 1 2015 13 (9) 1306-1315; DOI:10.1158/1541-7786.MCR-15-0130
Genomics

E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer

Chao Cheng, Frederick S. Varn and Carmen J. Marsit

Mol Cancer Res September 1 2015 13 (9) 1316-1324; DOI:10.1158/1541-7786.MCR-15-0120

Oncogenes and Tumor Suppressors

Oncogenes and Tumor Suppressors

Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations

John C. Hunter, Anuj Manandhar, Martin A. Carrasco, Deepak Gurbani, Sudershan Gondi and Kenneth D. Westover

Mol Cancer Res September 1 2015 13 (9) 1325-1335; DOI:10.1158/1541-7786.MCR-15-0203
Oncogenes and Tumor Suppressors

PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis

Alvaro Gutierrez-Uzquiza, Cynthia Lopez-Haber, Danielle L. Jernigan, Alessandro Fatatis and Marcelo G. Kazanietz

Mol Cancer Res September 1 2015 13 (9) 1336-1346; DOI:10.1158/1541-7786.MCR-15-0111

Signal Transduction

Signal Transduction

miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis

Xiaojuan Sun, Cherie Charbonneau, Lei Wei, Qian Chen and Richard M. Terek

Mol Cancer Res September 1 2015 13 (9) 1347-1357; DOI:10.1158/1541-7786.MCR-14-0697